JPRN-jRCTs031180014招募中未知
(F-18)FDG(F-18)FLT (3'-Deoxy-3'-(18F)fluorothymidine)PET/CT for malignant tumors - FDG and FLT PET-CT for malignant tumors
TATEISHI UKIHIDE0 个研究点目标入组 120 人开始时间: 2018年8月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20age 至 /A（—）
- 性别
- All
入选标准
- •Assured for (F-18) FDG PET/CT, greater than or equal to 20 year of age with written informed consent
排除标准
- •BS greater than or equal to 200mg/dl, pregnancy or suspected , without infromed consent
研究者
相似试验
已完成
不适用
18-Fluorothymidine positron emission tomography (18-FLT PET/CT) to assess tumour proliferation during radical radiotherapyLung cancerCancerISRCTN97398362Guy's and St. Thomas' NHS Foundation Trust (UK)20
已完成
不适用
Evaluation of 3'-deoxy-3'-[18F]fluorothymidine -PET and diffusion weighted imaging -MRI in patients with early stage non-small cell lung cancer treated with a platinum-based doublet as preoperative chemotherapy.Lungcancer10038666non-small cell lung cancerNL-OMON42040European Organisation for Research in Treatment of Cancer (EORTC)4
进行中（未招募）
1 期
18F-Fluorocholine (FCH) versus 18F-Fluorodesoxyglucose (FDG) PET/CT for the detection of lesions in patients with multiple myelomaPatient with multiple myeloma, addressed for initial evaluation and eligible for an autograft of Hematopoietic Stem Cells.MedDRA version: 21.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864EUCTR2019-003627-38-FRCentre Georges-François Leclerc38
进行中（未招募）
不适用
18F-Fluorothymidine Positron Emission Tomography as an early predictor of response to neoadjuvant therapy in patients with locally advanced breast carcinoma - NDBreast carcinoma classified as cT1b,c, T2, T3, or cT4 a-c, cN0-2, N3, M0MedDRA version: 9.1Level: HLTClassification code 10006289EUCTR2010-020472-34-ITISTITUTO EUROPEO DI ONCOLOGIA
进行中（未招募）
不适用
Combined 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and Metomidate Imaging for Adrenal Neoplasia (FAMIAN-Study) - a Diagnostic Studyindeterminate adrenal neoplasiasEUCTR2012-003604-13-DEniversity Hospital Wuerzburg220